CVS Health Corporation Common Stock (CVS) scored on five pillars from its reported financial statements, and ranked against 212 Healthcare companies.
CVS Health Corporation Common Stock (CVS) scores 4.5 out of 10 as of , computed from its reported financial statements. That reads as mixed quality. The reading rests on efficiency, and growth is what holds it back.
Data provided by Twelve Data. Scores are computed by Lemma Analysis from reported financials.
We cannot judge CVS Health Corporation Common Stock yet, because fewer than five years had both a return on capital and a cost of capital we could measure. This is not a “no”.
Quantitative signs of a moat, read from the filed statements. This is not a judgement of where it comes from (brand, network effects, switching costs). How Lemma measures a moat →
On the filings behind it, CVS Health Corporation Common Stock earns 4.5 out of 10 for business quality as of October 19, 2026. That is mixed quality on our scale. A mixed reading means the strengths and weaknesses roughly cancel out, and the case for the business depends on which pillars you care about most. The figure is a weighted average of five pillars, each scored from 0 to 10 against sector-aware benchmarks from reported statements.
Set against 212 Healthcare companies, CVS Health Corporation Common Stock lands at the 52nd percentile, above the middle of the group. A typical company in the group scores 4.4, and the best quarter starts from 6.0. CVS Health Corporation Common Stock is in line with that typical reading.
CVS Health Corporation Common Stock’s profitability score is 2.6 out of 10 (weak). Against a median of 2.7 among 210 Healthcare companies, that is in line with the group and the 50th percentile. Low margins and returns leave little cushion, so a downturn or a cost increase reaches the bottom line quickly.
On solvency, CVS Health Corporation Common Stock scores 4.3, an average reading. Its peers have a median of 6.5 across 150 Healthcare companies, which places it well below them, at the 19th percentile. Middling solvency says the balance sheet is neither a strength nor a constraint today.
On growth, CVS Health Corporation Common Stock scores 1.8, a weak reading. Its peers have a median of 4.9 across 107 Healthcare companies, which places it well below them, at the 15th percentile. When growth is this low the question is whether it is a pause or a trend, and the history behind the filings is the place to look.
Efficiency scores 8.7 out of 10, which reads as strong. The median across 200 Healthcare companies is 6.0, so CVS Health Corporation Common Stock is well above its peers on this pillar and ranks at the 92nd percentile. High efficiency means assets and earnings are being turned into cash and output better than at most peers, a sign of a well run operation.
On predictability, CVS Health Corporation Common Stock scores 6.5, an average reading. Its peers have a median of 3.4 across 207 Healthcare companies, which places it well above them, at the 86th percentile. Consistency near the median is typical, and it is worth checking whether the swings came from the business itself or from one-off items.
This is a lopsided profile. Efficiency scores 8.7 but growth only 1.8, a gap of 6.9 points, so the overall hides a business that is excellent in one respect and weak in another. An efficiency lead means the operation turns what it has into cash better than it does anything else. A growth shortfall often comes with size or a maturing market, and is less of a concern if the other pillars are strong.
Of everything that could lift CVS Health Corporation Common Stock’s score, growth matters most. Bringing it up to the 4.9 median of Healthcare companies would take the overall from 4.5 to roughly 5.1. All five pillars could be scored, so the overall uses the full set of weights out of 100: profitability 25, solvency 20, growth 20, efficiency 15, predictability 20.
These are the Healthcare companies closest to CVS Health Corporation Common Stock in market value. Each has its own page scored on the same five pillars, so the comparison is like for like.
How much profit the company generates from its capital and sales.
The company’s ability to service debt and meet its obligations.
How fast revenue, earnings and cash flow are compounding.
How well assets and earnings convert into cash and output.
How stable and consistent results have been over time.
Each metric is scored from 0 to 10 against sector-aware benchmarks, where higher is better. Metrics roll up into five pillars, and the pillars combine into the overall score using the weights shown. Sector-sensitive metrics are judged relative to peers in the same sector.
This score is a systematic, backward-looking read of reported fundamentals. It does not judge valuation, management quality, competitive moat, or future prospects, and can be distorted by one-off items or unusual accounting. Treat it as a starting point, not a recommendation.
Educational only. Not investment advice.
On this reading CVS Health Corporation Common Stock scores 4.5 out of 10, which reads as mixed quality. Its strongest pillar is efficiency, its weakest is growth. Quality is not the same as a good investment: the score says nothing about the price you would pay.
CVS Health Corporation Common Stock ranks at the 52nd percentile of the 212 Healthcare companies Lemma publishes a score for. The median there is 4.4 and the top quarter starts at 6.0, against CVS Health Corporation Common Stock’s 4.5.
Five pillars, each scored from 0 to 10 against sector-aware benchmarks and then weighted into one overall reading: profitability, solvency, growth, efficiency and predictability. Everything comes from reported financials, and nothing comes from price, sentiment or forecasts.
This page last changed on October 19, 2026. The score moves with the financial statements, so the page changes when a new filing moves the reading rather than on a schedule. Live figures for CVS are in the app.
No. Quality and valuation are separate questions, and a good business at the wrong price is still a bad purchase. Score the business here, then price it with a DCF you control.
Inside Lemma Analysis the same five pillars run on every company we cover, with the metrics behind each one, current fundamentals, a DCF you control and a watchlist that tells you when the price catches up.
Free to start · No credit card